Pharmaceuticals - Community Register


Community list of not active medicinal products for human use


Product information

Invented name: Destara
Auth. number : EU/1/96/013
Active substance : Ibandronic acid
ATC: Anatomical main group: M - Musculo-skeletal system
Therapeutic subgroup: M05 - Drugs for treatment of bone diseases
Pharmacological subgroup: M05B - Drugs affecting bone structure and mineralization
Chemical subgroup: M05BA - Biphosphonates
Chemical substance: M05BA06 - ibandronic acid
(See WHO ATC Index)
Indication: Treatment of tumour-induced hypercalcaemia with or without metastases.
Marketing Authorisation Holder: Roche Registration Limited
40 Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AY, United Kingdom
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/06/1996 Centralised - Authorisation EMEA/H/C/103 (96)1687 of 25/06/1996
28/10/1996 Centralised - Authorisation EMEA/H/C/103/II/2 (96)2980 of 25/10/1996
28/08/1997 Centralised - Authorisation EMEA/H/C/103/1/II/3, 4 (97)2745 of 27/08/1997
16/06/1998 Centralised - Variation (no change in Commission Decision) EMEA/H/C/103/I/7
21/10/1999 Centralised - Variation (no change in Commission Decision) EMEA/H/C/103/I/9-10
29/12/1999 Centralised - Transfer Marketing Authorisation Holder EMEA/H/C/103/T/8 (1999)4577 of 21/12/1999
02/02/2000 Centralised - Variation EMEA/H/C/103/I/11, 12 (2000)120 of 28/01/2000
29/06/2000 Centralised - Notification EMEA/H/C/103/N/13 (2000)1510 of 27/06/2000
14/09/2001 Centralised - Renewal EMEA/H/C/103/II/15, EMEA/H/C/103/II/16, EMEA/H/C/103/R/14 (2001)2196 of 12/09/2001
04/04/2002 Centralised - Variation EMEA/H/C/103/I/17 (2002)1368 of 27/03/2002
22/11/2006 Centralised - Withdrawal (not renewed)